期刊文献+

台州地区表观健康成人血清补体C1q参考区间的初步建立 被引量:1

Establishment on the reference ranges of serum complement C1q among apparently healthy adults in Taizhou
下载PDF
导出
摘要 目的探讨浙江台州地区表观健康成年人群血清补体C1q参考区间的建立,并分析血清补体C1q水平与其他常用临床检测指标的相关性。方法随机选取2016年2—3月在台州市中心医院进行健康体检的表观健康人群463名,其中男240名、女223名;采用免疫透射比浊法测定血清中补体C1q的含量;采用正态分布法的双侧95%可信区间确定参考区间。结果血清补体C1q水平在研究人群中呈正态分布,健康成人女性血清含量为(210.3±25.6)mg/L,高于男性的(197.8±26.1)mg/L(P<0.01)。相关分析显示,血清补体C1q与球蛋白、白细胞(WBC)、总胆固醇(TC)呈正相关(r>0,P<0.05),与血肌酐(Cr)、血红蛋白(Hb)呈负相关(r<0,P<0.05),与年龄等无相关性(P>0.05)。结论健康成人血清补体C1q的含量存在性别差异,建议不同性别的台州地区人群分别建立补体C1q的参考范围。 Objective To establish the reference ranges of serum complement C1q among apparently healthy adults in Taizhou,and to investigate the relationship between complement C1q and other parameters. Methodse A total of 463 apparently healthy adults were enrolled in Taizhou Central Hospital from February 2016 to March 2016,including 240 males and 223 females. Serum complement C1q was determined by turbidimetric inhibition immunoassay. The reference ranges were expressed by bilateral 95% confidence interval of normal distribution. Results The levels of complement C1q were expressed as normal distribution. The level of complement C1q in females [(210.3±25.6) mg/L] was higher than that in males [(197.8±26.1) mg/L](P〈0.01). Complement C1q had positive correlations with globulin,white blood cell (WBC),total cholesterol (TC) (r〉0,P〈0.05),and had negative correlations with creatinine (Cr) and hemoglobin (Hb)(r〈0,P〈0.05). There was no correlation with ages (P〉0.05). Conclusions The level of complement C1q in healthy adults has difference between males and females. The reference ranges of complement C1q should be established for males and females in Taizhou respectively.
出处 《检验医学》 CAS 2017年第5期403-405,共3页 Laboratory Medicine
关键词 补体C1Q 参考区间 免疫透射比浊法 Complement C1q Reference ranges Turbidimetric inhibition immunoassay
  • 相关文献

参考文献2

二级参考文献57

  • 1周滨,张奉春,董怡.补体C1q及抗C1q抗体与系统性红斑狼疮及狼疮肾炎相关性的研究[J].中华风湿病学杂志,2005,9(12):725-728. 被引量:23
  • 2Kolev M, Le Friee G, Kemper C. Complement tapping into new sites and effector systems[J]. Nat Rev Immunol,2014,14 ( 12 ) : 811-820.
  • 3Zipfel PF, Skerka C. Complement regulators and inhibitory proteins[J].Nat Rev Immunol, 2009, 9 (10) :729-740.
  • 4Sj6berg AP, Trouw LA, Blom AM. Complement activation aml inhibition: a delicate balance [J]. Trends Immunol, 2009,30 (2) :83-90,.
  • 5唐慧一,程惠芳,朱世乐,等.肾脏病时测定血清补体第一成份亚单位(C1q)的临床意义[J].北京大学学报(医学版),1985,1(1):24.
  • 6Larsen CP, Messias NC, Silva FG, et al. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies [ J ]. Mod Pathol, 2013, 26(5):709-715.
  • 7Kozyro I, Korosteleva L, Chemoshej D, et al. Autoantibodies against complement C1 q in acute post-streptococcal glomerulonephritis [ J ]. Clin Immunol, 2008,128 ( 3 ) :409-414.
  • 8Kallel-Sellami M, Baili-Klila L, Zerzeri Y, et aI. Pediatric systemic lupus erythematosus with Clq deficiency[ J]. Ann N Y Acad Sci, 2007,1108 ( 1 ) : 193-196.
  • 9Botto M, Walport MJ. Clq, autoimmunity and apoptosis[ J]. Immunobiology, 2002, 205 (4-5) :395-406.
  • 10Stegert M, Bock M, Trendelenburg M. Clinical presentation of human Clq deficiency: How much of a lupus.'? [ J ]. Mol Immunol, 2015, 67 ( 1 ) :3-11.

共引文献38

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部